BioSpace News Archive

Genetown

Aramis Biosciences Launches to Address Unmet Needs in Ocular Immunology

Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the completion of a $10.5 million Series A financing led by Safar Partners with a strategic investment from a global leader in ophthalmic pharmaceuticals.

December 15, 2021
·
6 min read
Deals

Agomab Therapeutics Completes Acquisition of Origo Biopharma

Agomab Therapeutics NV announced the closing of the Origo Biopharma acquisition.

December 15, 2021
·
1 min read
Ei.Ventures Closes Out an Exciting 2021, Heads into 2022 Leading the Way in Psychedelic Medicine Development, Fundraising and more

First and foremost the Ei.Ventures’ Reg A+ raise has been incredible. Support from investors from all over the country has topped expectations. As it stands, Ei.Ventures has raised $19,914,863 of a $50 million qualification.

December 15, 2021
·
5 min read
Lone Star Bio

Greenwich LifeSciences CEO Participates in TD Ameritrade Interview to Discuss 2021 SABCS Poster

Greenwich LifeSciences, Inc. announced that CEO Snehal Patel participated in a TD Ameritrade interview to discuss the Phase IIb poster presented at the 2021 San Antonio Breast Cancer Symposium on December 9, 2021.

December 15, 2021
·
6 min read
FDA

ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features

ViewRay, Inc. (NASDAQ: VRAY) today announced that the company received FDA 510(k) clearance for its next generation of MRI-guided radiation therapy features, focused on enhancing on-table adaptive workflow.

December 15, 2021
·
6 min read
Pharm Country

NRx Pharmaceuticals Added to the Nasdaq® Biotech Index

NRx Pharmaceuticals announced that Nasdaq has added the company to the Nasdaq Biotechnology Index effective December 20, 2021.

December 15, 2021
·
3 min read
Deals

Tonix Pharmaceuticals Added to the Nasdaq Biotechnology Index

Tonix Pharmaceuticals Holding Corp. today announced that it has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI) as part of the Nasdaq’s annual reconstitution process.

December 15, 2021
·
4 min read
Pharm Country

New Data Suggest COVAXIN™ (BBV152) Vaccine Candidate Generates Robust Immune Memory to COVID-19 and Variants of Concern for At Least Six Months After Vaccination

Ocugen, Inc. announced that data analyzing immune response following two doses of the vaccine candidate, COVAXIN™ (BBV152), from a third-party study were published on the preprint server, medRxiv.

December 15, 2021
·
9 min read
Job Trends

Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting

Eli Lilly and Company (NYSE: LLY) is providing extensive updates across its research and development (R&D) programs to highlight the company’s strong pipeline and potential for future growth.

December 15, 2021
·
17 min read
Ilumed Raises $16.5 Million Series A Financing

Financing round was led by Ascend Partners with participation from several angel investors.

December 15, 2021
·
3 min read